6mg Lupifil P Pegfilgrastim Injection

Name: 6mg Lupifil P Pegfilgrastim Injection
Brand: Amari Trade Alliance LLP
Price: 3400 INR
Availability: InStock

Price 3400 INR/ Piece

Get a Price/Quote

MOQ : 4 Vials

6mg Lupifil P Pegfilgrastim Injection Specification

Origin of Medicine
India

Dosage Form
Parenteral

Life Span
24 months

Indication
To reduce infection risk during chemotherapy

Salt Composition
Pegfilgrastim

Packaging Type
Pre-filled syringe (PFS)

Brand Name
Lupifil P

Pacakaging (Quantity Per Box)
1 syringe per box

Drug Type
Biologic

Ingredients
Pegfilgrastim

Physical Form
Injection

Function
Stimulates white blood cell production

Recommended For
Prevention of chemotherapy-induced neutropenia

Dosage
6 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
1 pre-filled syringe

Storage Instructions
Store between 2C - 8C

Primary Use
Oncology supportive care

FDA Status
Approved

Prescription
Rx only

Cap Color
Violet

Route
Subcutaneous

Sterility
Sterile solution

Country
India

Market segment
Hospital supply

Strength
6 mg

6mg Lupifil P Pegfilgrastim Injection Trade Information

Minimum Order Quantity
4 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

About 6mg Lupifil P Pegfilgrastim Injection

Discover the new and customizable 6mg Lupifil P Pegfilgrastim Injection, renowned for its effectiveness in oncology supportive care. This sterile, pre-filled syringe contains the exquisite strength of Pegfilgrastim, specifically formulated for subcutaneous administration to adult patients. Heroic in its function, Lupifil P stimulates white blood cell production, significantly reducing the risk of infection during chemotherapy. FDA-approved and manufactured in India, this solution boasts a violet cap and a trusted reputation in hospital supply. Redeem the promise of safety and care, prescribed only by healthcare professionals.

Usage, Applications & Competitive Edge

6mg Lupifil P Pegfilgrastim Injection is primarily used for the prevention of chemotherapy-induced neutropenia in adults. As an oncology supportive care solution, it is administered via subcutaneous injection and manufactured in state-of-the-art facilities. Its plant application adheres to strict quality standards, ensuring reliability. The primary competitive advantages include FDA approval, sterile pre-filled syringes, long shelf life, and renowned efficacy-all making it a trusted choice for hospital supply and patient safety.

Export Markets, Packaging & Certifications

Lupifil P Pegfilgrastim Injection enjoys a strong rate of demand in major export markets worldwide, including Asia, the Middle East, Africa, and Latin America. Each sterile syringe is individually packaged for optimal safety and storage, ensuring quick dispatch and secure transit. Certifications such as FDA approval and GMP compliance contribute to its global recognition. Packaging conforms to hospital requirements, further elevating its reputation among international suppliers and traders.

FAQ's of 6mg Lupifil P Pegfilgrastim Injection:

Q: How should Lupifil P Pegfilgrastim Injection be administered?

A: Lupifil P should be administered as a subcutaneous injection by a healthcare professional, following the prescribed dosage guidelines.

Q: What is the primary benefit of using this injection during chemotherapy?

A: The primary benefit is the prevention of chemotherapy-induced neutropenia, reducing the risk of infection by stimulating white blood cell production.